Trial · NCT00425711
Study of Acamprosate in Driving Under the Influence (DUI) Court Participants
NCT00425711, Not applicable, Terminated, University of Oklahoma
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of Acamprosate in Driving Under the Influence (DUI) Court Participants. Trials, record NCT00425711. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00425711
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of Acamprosate in Driving Under the Influence (DUI) Court Participants
- NCT number
- NCT00425711
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 4 participants, actual
- Lead sponsor
- University of Oklahoma
- Conditions
- Alcohol Dependence
- Interventions
- Acamprosate
- First posted
- 2007-01-23
- Last updated
- 2026-04-06
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | time until relapse, i.e. any alcohol consumption | Baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Admission to residential treatment or jail | baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Depressive symptoms as measured by the Beck Depression Inventory II | baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Anxiety symptoms as measured by the Beck Anxiety Inventory | baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Penn Alcohol Craving Scale scores | baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Obsessive Compulsive Drinking Scale scores | baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Adverse events | baseline and weeks 2, 4, 8, and 12 | |
| Secondary | Proportion of days on which alcohol was consumed | baseline and weeks 2, 4, 8, and 12 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00425711
GET https://conductscience.org/api/trials/v1/NCT00425711/registered